Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma

NCT06433947 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Multiple Myeloma
Refractory Multiple Myeloma

Interventions

DRUG: OPN-6602
DRUG: Dexamethasone

Sponsor

Opna Bio LLC